Your browser doesn't support javascript.
loading
Case Report: Refractory Cryptosporidiosis after CAR T-Cell Therapy for Lymphoma.
Trottier, Caitlin A; Yen, Christina F; Malvar, Grace; Arnason, Jon; Avigan, David E; Alonso, Carolyn D.
Afiliação
  • Trottier CA; 1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Yen CF; 2Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Malvar G; 3Division of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Arnason J; 4Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Avigan DE; 5Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Alonso CD; 2Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Am J Trop Med Hyg ; 105(3): 651-653, 2021 07 08.
Article em En | MEDLINE | ID: mdl-34237021
ABSTRACT
Cryptosporidial diarrhea is uncommon in immunocompetent individuals, more often seen in severely immunocompromised patients. Severe refractory cases have been described in patients with HIV/AIDS before the advent of modern antiretroviral therapy due to an inability to mount an adequate cellular immune response. We describe an 85-year-old patient post-chimeric antigen receptor T-cell therapy relapsed lymphoma who developed refractory Cryptosporidium spp. diarrhea in the setting of persistent CD4+ cytopenia. Despite receiving multiple antiparasitic agents, including failure of a prolonged course of nitazoxanide, the patient experienced persistent symptoms for 9 months with repeatedly positivity stool Cryptosporidium spp. direct fluorescent antibody (DFA) test. We highlight this case of refractory Cryptosporidium spp. and the importance of recognizing the pathogen in a non-HIV-infected immunosuppressed host.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células B / Criptosporidiose Tipo de estudo: Etiology_studies Limite: Aged80 / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células B / Criptosporidiose Tipo de estudo: Etiology_studies Limite: Aged80 / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article